← FDA Drug Approvals (Drugs@FDA)

SILODOSIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2025-02-10

Drug application

FDA Application #
ANDA210396
Application type
Abbreviated New Drug Application (Generic)
Brand name
SILODOSIN
Generic name
Silodosin
Active ingredients
SILODOSIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Discontinued
Sponsor
TORRENT
First approval
2025-02-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown